Target intelligence / Profile preview

Oxidized lipid (No universally recognized abbreviation; sometimes OxPL or OxL.)

Target
No universally recognized abbreviation; sometimes OxPL or OxL.
Molecular classification
Other (not a receptor, enzyme, transporter, etc.), Lipid derivative, Lipid oxidation product, Signaling molecule (subset), DAMP (damage-associated molecular pattern; subset)
01

Overview

Oxidized lipids are a chemically diverse class of lipid molecules produced by enzymatic (e.g., lipoxygenases, cyclooxygenases) and non-enzymatic (e.g., free-radical mediated) oxidation of polyunsaturated fatty acids in cellular membranes and lipoproteins. They include oxidized phospholipids, cholesterol oxidation products (oxysterols), oxidized fatty acid metabolites (e.g., isoprostanes), and lipid peroxidation adducts (such as malondialdehyde and 4-HNE). Oxidized lipids play key roles as signaling mediators in inflammation, cell death, immune activation, and metabolic regulation, but in excess contribute to tissue injury and the development of cardiovascular, neurodegenerative, and other chronic diseases. Due to their immense chemical diversity, "oxidized lipid" is not a precise molecular target, but specific oxidized lipid species are increasingly recognized as disease biomarkers and potential drug targets within defined contexts.

Other names
Oxidized phospholipid (OxPL)Lipid peroxidation productOxidized fatty acidOxysterol (for oxidized cholesterol derivatives)Oxylipin (for oxygenated fatty acid derivatives)Lipid oxidation product
02

Mechanism of action

Drugs interact with oxidized lipids primarily through antioxidant scavenging to prevent or reduce their formation, inhibition of oxidative enzymes (e.g., targeting lipoxygenase/cyclooxygenase pathways), or neutralization/binding (e.g., via monoclonal antibodies to specific oxidized lipid species).

03

Biological functions

Modulation of inflammation (pro- and anti-inflammatory effects)Signal transduction in cell death pathways (e.g., apoptosis, ferroptosis)Immune system activation/recognition (by pattern recognition receptors such as TLRs and scavenger receptors)Regulator of endothelial permeability and vascular functionModulation of coagulation and platelet activationInduction of oxidative stress and cytotoxicity (at high concentrations)Biomarker for oxidative stress and tissue injuryRegulation of antioxidant responses
04

Disease associations

Cardiovascular disease, particularly atherosclerosisInflammatory diseases (general)Neurodegenerative diseases (e.g., Alzheimer's disease)Pulmonary diseases, including acute lung injuryNon-alcoholic steatohepatitis/metabolic disordersCancerAgingOther (widespread biomarker and modulator roles in tissue injury, infection, etc.)
05

Safety considerations

Oxidized lipids themselves are often toxic, pro-inflammatory, and cytotoxic at high levelsBroad inhibition or scavenging risks disrupting normal lipid signaling and homeostasisPotential off-target effects on beneficial lipid oxidation pathways (e.g., in immune resolution or homeostatic signaling)High molecular diversity makes development of specific, selective modulators or biomarkers challenging
06

Interacting drugs

Antioxidants (e.g., vitamin E, probucol) - for scavenging

5 more in the full profile.

07

Biomarkers

Specific oxidized phospholipids (e.g., OxPAPC) as markers of oxidative stressMalondialdehyde (MDA) as a lipid peroxidation readout4-hydroxy-2-nonenal (4-HNE) as a lipid peroxidation readoutF2-isoprostanes (oxidized fatty acid markers)Oxysterols in plasma/CSF

Beyond the preview

Go deeper on Oxidized lipid (No universally recognized abbreviation; sometimes OxPL or OxL.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxidized lipid (No universally recognized abbreviation; sometimes OxPL or OxL.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call